eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | oligodendroglioma |
| Comorbidity | C0017636|glioblastomas |
| Sentences | 4 |
| PubMedID- 24264532 | This study was designed to display the molecular genetic features of short-term survivors in glioblastomas with oligodendroglioma component (gbmo). |
| PubMedID- 24118308 | In the few cases of oligoastrocytomas and glioblastomas with an oligodendroglioma component (gbmo) where only 1p deletion was described, the origin remains unknown. |
| PubMedID- 25007776 | 1q, 19p and co-polysomy were confirmed as risk factors conveyed unfavorable outcomes, which has been further validated in both anaplastic oligodendroglial tumors (aogs) (p = 0.07, p = 0.028 and p = 0.054 for pfs; p = 0.007, p = 0.001 and p = 0.002 for os, respectively) and glioblastomas with oligodendroglioma component (gbmos) (p = 0.005, p < 0.001 and p < 0.001 for pfs; p = 0.136, p = 0.006 and p = 0.051 for os, respectively). |
| PubMedID- 25854377 | Astrocytoma showed lower s100a4 mrna expression than oligodendrogliomas, with glioblastomas having highest values (p<0.001). |
Page: 1